Related Experiment Video
Updated: Mar 19, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
Agrimol B suppresses adipogenesis through modulation of SIRT1-PPAR gamma signal pathway
Shifeng Wang1, Qiao Zhang1, Yuxin Zhang1
1School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.
Abstract:
Studies of human genetics have implicated the role of SIRT1 in regulating obesity, insulin resistance, and longevity. These researches motivated the identification of novel SIRT1 activators. The current study aimed to investigate the potential efficacy of agrimol B, a polyphenol derived from Agrimonia pilosa Ledeb., on mediating SIRT1 activity and fat metabolism. Results showed that agrimol B significantly induced cytoplasm-to-nucleus shuttle of SIRT1. Furthermore, we confirmed that agrimol B dramatically inhibited 3T3-L1 adipocyte differentiation by reducing PPARγ, C/EBPα, FAS, UCP-1, and apoE expression. Consequently, adipogenesis was blocked by treatment of agrimol B at the early stage of differentiation in a dose-dependent manner, the IC50 value was determined as 3.35 ± 0.32 μM. Taken together, our data suggest a therapeutic potential of agrimol B on alleviating obesity, through modulation of SIRT1-PPARγ signal pathway.
Insights
Agrimol B, a natural polyphenol, activates SIRT1 and inhibits fat cell differentiation by reducing key gene expressions. This suggests its potential for treating obesity via the SIRT1-PPARγ pathway.
Area of Science:
- Metabolic research
- Molecular biology
- Pharmacology
Background:
- Sirtuin 1 (SIRT1) is implicated in obesity, insulin resistance, and longevity.
- Novel SIRT1 activators are sought for therapeutic applications.
- Agrimol B is a polyphenol from Agrimonia pilosa Ledeb.
Purpose of the Study:
- To investigate agrimol B's efficacy on SIRT1 activity.
- To explore its effects on fat metabolism and adipocyte differentiation.
- To elucidate its potential therapeutic role in obesity.
Main Methods:
- Assessed SIRT1 localization (cytoplasm-to-nucleus shuttle).
- Evaluated 3T3-L1 adipocyte differentiation.
- Measured expression levels of key genes (PPARγ, C/EBPα, FAS, UCP-1, apoE).
- Determined the IC50 value for adipogenesis inhibition.
Main Results:
- Agrimol B induced SIRT1 cytoplasm-to-nucleus translocation.
- It significantly inhibited 3T3-L1 adipocyte differentiation.
- Gene expression of PPARγ, C/EBPα, FAS, UCP-1, and apoE was reduced.
- Adipogenesis was blocked dose-dependently with an IC50 of 3.35 ± 0.32 μM.
Conclusions:
- Agrimol B modulates SIRT1 activity and fat metabolism.
- It effectively inhibits adipogenesis by targeting the SIRT1-PPARγ pathway.
- Agrimol B shows therapeutic potential for obesity management.
More Related Videos
06:08Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
11:11Adipocyte-Specific ATAC-Seq with Adipose Tissues Using Fluorescence-Activated Nucleus Sorting
Published on: March 17, 2023
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
Cell Specific Gene Expression
Regulation of Food Intake